MedTrace Logo

Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children

NCT06137560 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2025-04-17

No results posted yet for this study

Summary

There are two parts to this trial. First, to compare the rate of myopia progression of spectacle films using Spatio Temporal Optic Phase (S.T.O.P.®) technology that provide a dynamic optical cue against single vision spectacle lenses. Second, to compare the rate of myopia progression of spectacle films using S.T.O.P.® technology that provide a dynamic optical cue against spectacle films using S.T.O.P.® technology that provide a static optical cue. A dynamic optical cue is one that changes, and a static optical cue is one that does not change.

Conditions

  • Myopia

Interventions

DEVICE

Single vision spectacle lens

Standard single vision spectacle lens

DEVICE

Single vision spectacle lens + S.T.O.P.® Kit 1

Standard single vision spectacle lens + S.T.O.P.® Kit 1

DEVICE

Single vision spectacle lens + S.T.O.P.® Kit 2

Standard single vision spectacle lens + S.T.O.P.® Kit 2

DEVICE

Single vision spectacle lens + S.T.O.P.® Film

Standard single vision spectacle lens + S.T.O.P.® Film

DEVICE

Standard single vision spectacle lens + S.T.O.P.® Kit 1 or 2

Standard single vision spectacle lens + S.T.O.P.® Kit 1 or 2

Sponsors & Collaborators

  • Zhong Jing Wei Shi (Suzhou) Optical Technology Ltd.

    collaborator UNKNOWN

  • nthalmic Pty Ltd

    lead NETWORK

Principal Investigators

  • Daniel Tilia, Optom, PhD · nthalmic Pty Ltd

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-22
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • China
  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06137560 on ClinicalTrials.gov